V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20163153 | 20062929 | 1.7 | 106 | Palliative (P) | 2018-07-14 | 2018-07-23 | ECX | N | N | ECX | 100518879 |
| 20163160 | 20062930 | 1.67 | 78.5 | Neo-adjuvant (N) | 2018-02-04 | 2018-02-04 | Gemcitabine + Capecitabine | N | N | ECX | 100028584 |
| 20163161 | 20062931 | 1.62 | null | Palliative (P) | 2018-04-22 | 2018-04-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101407004 |
| 20163162 | 20062932 | null | null | Palliative (P) | null | 2016-08-12 | ECX | N | N | ECX | 101144079 |
| 20163164 | 20062933 | 1.6 | 67.5 | null | 2018-04-12 | 2018-04-16 | ECX | 02 | N | ECX | 100264374 |
| 20163168 | 20062934 | 1.81 | 65.4 | Adjuvant (A) | 2017-01-21 | 2017-02-04 | ECX | N | N | ECX | 101654945 |
| 20163169 | 20062935 | 1.67 | 51.85 | Palliative (P) | 2017-06-20 | 2017-06-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100989730 |
| 20163171 | 20062936 | 1.66 | 71 | Palliative (P) | 2016-08-20 | 2016-08-20 | ECX | N | N | ECX | 100097039 |
| 20163187 | 20062937 | 1.57 | 65.6 | Neo-adjuvant (N) | 2017-03-15 | 2017-03-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100042657 |
| 20163190 | 20062938 | 1.72 | 46.2 | Palliative (P) | 2020-01-10 | 2020-01-13 | ECX | N | N | ECX | 100696000 |
| 20163197 | 20062939 | null | 86 | Neo-adjuvant (N) | 2016-10-21 | 2016-11-04 | ECX | 02 | N | ECX | 100474416 |
| 20163212 | 20062940 | 1.58 | 55.6 | Palliative (P) | 2017-08-21 | 2017-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100643725 |
| 20163214 | 20062941 | 1.53 | 53.55 | Neo-adjuvant (N) | 2018-03-17 | 2018-03-17 | ECX | 2 | N | ECX | 100321166 |
| 20163229 | 20062942 | 1.68 | 93 | Palliative (P) | 2020-01-04 | 2020-01-30 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100924555 |
| 20163231 | 20062943 | 1.81 | 69.4 | Palliative (P) | 2016-07-10 | 2016-07-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100851349 |
| 20163234 | 20062944 | 1.71 | 79.1 | Palliative (P) | 2017-12-23 | 2018-01-05 | ECX | N | N | ECX | 101570204 |
| 20163254 | 20062945 | 1.8 | 76 | Adjuvant (A) | 2017-04-25 | 2017-04-26 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100934447 |
| 20163256 | 20062946 | 1.79 | 53.3 | Adjuvant (A) | 2016-08-12 | 2016-08-15 | ECX | 2 | N | ECX | 100856665 |
| 20163263 | 20062947 | 1.89 | 73 | Palliative (P) | 2017-05-21 | 2017-06-08 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101447958 |
| 20163273 | 20062948 | 1.78 | 66.6 | Palliative (P) | 2016-05-18 | 2016-06-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100584773 |
| 20163274 | 20062949 | 1.6 | 76 | Palliative (P) | 2016-04-21 | 2016-05-04 | ECX | 02 | N | ECX | 100824668 |
| 20163276 | 20062950 | 1.7 | 56.4 | Neo-adjuvant (N) | 2018-08-11 | 2018-08-20 | ECX | N | null | ECX | 100680647 |
| 20163292 | 20062951 | 1.82 | 109.7 | Adjuvant (A) | 2019-08-01 | 2019-08-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101552921 |
| 20163294 | 20062952 | 1.72 | 68.7 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100748107 |
| 20163298 | 20062953 | 1.8 | 98.9 | Neo-adjuvant (N) | 2019-02-26 | 2019-03-05 | ECX | 02 | null | ECX | 101178015 |
| 20163299 | 20062954 | null | null | Curative (C) | 2017-11-01 | 2017-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100557018 |
| 20163313 | 20062955 | 1.69 | 81 | Neo-adjuvant (N) | 2018-10-23 | 2018-11-06 | ECX | N | N | ECX | 101350857 |
| 20163315 | 20062956 | 1.77 | 71 | Palliative (P) | 2018-12-05 | 2018-12-15 | ECX | N | N | ECX | 100332486 |
| 20163316 | 20062957 | 1.66 | 66.4 | Neo-adjuvant (N) | 2019-08-03 | 2019-08-03 | ECX | N | N | ECX | 101025380 |
| 20163318 | 20062958 | 1.65 | 57.3 | Neo-adjuvant (N) | 2016-07-15 | 2016-07-27 | ECX | N | N | ECX | 101835964 |
| 20163319 | 20062959 | 1.48 | 87.8 | Adjuvant (A) | 2016-09-15 | 2016-09-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101174775 |
| 20163327 | 20062960 | 1.54 | 57 | Neo-adjuvant (N) | 2019-05-08 | 2019-05-16 | ECX | 02 | null | ECX | 100704145 |
| 20163336 | 20062961 | 1.71 | 55.9 | null | null | 2016-10-16 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100742294 |
| 20163337 | 20062962 | 1.7 | 87 | Palliative (P) | 2019-01-17 | 2019-01-24 | ECX | 02 | N | ECX | 101094102 |
| 20163338 | 20062963 | 1.73 | 82.8 | Curative (C) | 2019-12-06 | 2019-12-06 | ECX | N | N | ECX | 100169226 |
| 20163339 | 20062964 | 1.6 | 86.6 | Palliative (P) | 2016-08-18 | 2016-08-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100722084 |
| 20163343 | 20062965 | 1.77 | 78 | Palliative (P) | 2019-11-03 | 2019-11-06 | ECX | N | N | ECX | 100265450 |
| 20163348 | 20062966 | 1.57 | 73 | Palliative (P) | 2018-06-14 | 2018-06-14 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100486716 |
| 20163359 | 20062967 | 1.8 | 71.4 | Palliative (P) | 2018-08-19 | 2018-09-02 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100795069 |
| 20163362 | 20062968 | null | 62.6 | Adjuvant (A) | 2018-09-22 | 2018-10-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101673442 |
| 20163367 | 20062969 | 1.7 | 96.8 | Palliative (P) | 2016-04-10 | 2016-04-16 | ECX | 02 | N | ECX | 100382369 |
| 20163376 | 20062970 | 1.69 | 71.4 | Palliative (P) | 2018-12-24 | 2019-01-20 | ECX | N | N | ECX | 100790636 |
| 20163381 | 20062971 | 1.69 | 49.1 | Palliative (P) | 2020-02-14 | 2020-02-16 | ECX | N | N | ECX | 101075471 |
| 20163383 | 20062972 | 1.9 | 59 | Adjuvant (A) | 2017-02-06 | 2017-02-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100782119 |
| 20163388 | 20062973 | 1.7 | 83.65 | Neo-adjuvant (N) | 2017-02-12 | 2017-02-25 | ECX | N | N | ECX | 100207204 |
| 20163394 | 20062974 | 1.77 | 66.7 | Palliative (P) | 2018-01-26 | 2018-02-03 | ECX | N | N | ECX | 101609891 |
| 20163406 | 20062975 | 1.83 | 90.8 | Neo-adjuvant (N) | 2019-07-10 | 2019-07-14 | ECX | N | N | ECX | 101031624 |
| 20163409 | 20062976 | 1.69 | 68.3 | Neo-adjuvant (N) | 2019-07-24 | 2019-08-01 | ECX | 2 | N | ECX | 100903793 |
| 20163410 | 20062977 | 1.78 | 76.8 | Neo-adjuvant (N) | 2016-10-30 | 2016-11-06 | ECX | N | N | ECX | 101408161 |
| 20163411 | 20062978 | 1.75 | 80.4 | null | 2017-07-14 | 2017-08-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100089204 |